Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [09/16/2025 10:29 PDT] Helius Medical Technologies, Inc. (NASDAQ:HSDT), Up By 100% ($18.27) From $18.27 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [09/16/2025 07:24 PDT] HSDT Expected to Trade Up Short Term
• [07/31/2025 12:04 PDT] Helius Medical Technologies, Inc. (NASDAQ:HSDT), Down By 100% ($8.82) From $8.82 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [07/24/2025 07:15 PDT] HSDT Expected to Trade Down After Bearish Patterns Develop
• [07/21/2025 10:29 PDT] Helius Medical Technologies, Inc. (NASDAQ:HSDT), Up By 100% ($9.48) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, July 1st 2025 at a Price of $9.48.